Medicare Enrolled
Dr. Richard Rothschild, MD
Interventional Cardiology · Oxnard, CA
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Speaking/Promotional
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Rothschild from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Rothschild?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Rothschild
Dr. Richard Rothschild is an interventional cardiology specialist in Oxnard, CA, with 20 years of NPI registration. Based on federal Medicare data, Dr. Rothschild performed 10,939 Medicare services across 5,135 unique beneficiaries.
Between the years covered by Open Payments, Dr. Rothschild received a total of $64,143 from 51 pharmaceutical and/or device companies across 1038 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in interventional cardiology. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Rothschild is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice
▲ Top 8% volume in CA
$64,143 industry payments
Medicare Practice Summary
Medicare Utilization ↗10,939
Medicare services
Top 8% in CA for interventional cardiology
5,135
Unique beneficiaries
$95
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~547 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Chronic care management, additional 20 min/month This service covers an extra 20 minutes of clinical staff time directed by a healthcare professional for managing two or more chronic conditions each calendar month. |
1,365 | $40 | $111 |
| Remote vital sign monitoring management, each additional 20 minutes This code covers the time spent by a provider managing patient data from remote vital sign monitoring devices. It applies to each additional 20-minute increment beyond the initial monthly service period. |
1,125 | $34 | $95 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
1,074 | $147 | $300 |
| Remote patient monitoring management, 20 min/month Management based on results from remote vital sign monitoring for the first 20 minutes per calendar month. |
817 | $43 | $124 |
| Electrocardiogram (EKG), 12-lead A standard heart rhythm test using at least 12 leads to record electrical activity. A healthcare provider interprets the results and provides a written report. |
791 | $12 | $66 |
| Chronic care management, first 20 min/month This service covers the first 20 minutes of clinical staff time directed by a healthcare professional each calendar month to manage chronic conditions. |
765 | $54 | $144 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
535 | $105 | $175 |
| Regadenoson injection (Lexiscan) for heart stress test An injection of regadenoson, a medication used to stress the heart during diagnostic testing. |
496 | $44 | $88 |
| Remote patient monitoring device, 30 days Initial setup of devices for remote monitoring of body functions with daily data transmission or alerts. This service covers the first 30 days of the monitoring period. |
478 | $47 | $119 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
463 | $101 | $388 |
| Echocardiogram, transthoracic An ultrasound of the heart that uses color to show blood flow, rate, direction, and valve function. |
285 | $176 | $921 |
| Remote physiologic monitoring setup and education Initial setup of remote monitoring equipment and patient education on its use. |
278 | $18 | $65 |
| Rubidium rb-82, diagnostic, per study dose, up to 60 millicuries | 246 | $417 | $1,000 |
| Office visit for established patient An office visit for an existing patient that may not require the healthcare professional to be present. |
194 | $19 | $45 |
| Remote cardiac rhythm monitor evaluation, up to 30 days Review and analysis of data from a remote cardiac rhythm monitoring system over a period of up to 30 days. |
166 | $21 | $85 |
| Remote monitoring of implantable heart device, up to 30 days Remote evaluation of an implanted heart or blood vessel monitoring system over a period of up to 30 days. |
144 | $21 | $80 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
142 | $147 | $388 |
| Exercise or drug-induced heart stress test with ECG A heart stress test performed using exercise or medication while monitoring the electrocardiogram under physician supervision and review. |
129 | $62 | $371 |
| Ultrasound of head and neck blood flow, bilateral An ultrasound exam that uses sound waves to visualize and assess blood flow in the vessels of both the head and the neck. |
128 | $175 | $570 |
| Stress echocardiogram with ECG monitoring An ultrasound of the heart performed while monitoring heart rhythm during rest, exercise, or medication-induced stress, followed by a review and report of the findings. |
127 | $206 | $998 |
| Echocardiogram, transthoracic An ultrasound test that uses sound waves to create images of the heart's blood flow, valves, and chambers. |
122 | $42 | $220 |
| Echocardiogram with color Doppler An ultrasound of the heart that uses color imaging to visualize blood flow, measure flow rate, and assess valve function. |
122 | $20 | $230 |
| Remote pacemaker monitoring, 90 days Remote assessment of a pacemaker system, including single, dual, multiple lead, or leadless devices, performed up to 90 days apart. |
111 | $24 | $90 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
94 | $67 | $250 |
| Critical care, first 30-74 min Emergency medical care for a critically ill or injured patient lasting between 30 and 74 minutes. This service involves direct patient care and medical decision making to stabilize the patient. |
91 | $178 | $660 |
| Nuclear stress test with CT scan A nuclear medicine imaging test that evaluates blood flow in the heart muscle at rest and during stress, performed alongside a concurrent CT scan. |
82 | $1,745 | $3,500 |
| PET scan of heart muscle blood flow A nuclear medicine imaging test that uses positron emission tomography (PET) to evaluate blood flow within the heart muscle. |
82 | $124 | $400 |
| Cardiac catheterization | 45 | $200 | $1,000 |
| 2-day continuous ECG with review and report A two-day continuous electrocardiogram recording that includes a professional review and written report of the results. |
42 | $62 | $400 |
| Nuclear stress test of heart muscle A nuclear medicine imaging test that evaluates blood flow to the heart muscle while at rest and during stress. |
41 | $1,360 | $4,000 |
| Remote evaluation of implantable defibrillator system Remote assessment of a single, dual, or multiple lead implantable defibrillator system within 90 days of the previous evaluation. |
39 | $30 | $120 |
| Pacemaker programming, dual lead system Adjustment and configuration of a dual-lead pacemaker device to ensure proper operation and settings. |
38 | $65 | $140 |
| Continuous external EKG monitoring, 48 hours to 7 days This procedure involves recording the heart's electrical activity continuously using an external device for a period exceeding 48 hours but not more than 7 days. |
36 | $11 | $35 |
| Continuous EKG monitoring review, 48-7 days Review and interpretation of continuous external EKG recordings lasting more than 48 hours up to 7 days. |
36 | $20 | $60 |
| New patient office visit, complex (60-74 min) | 31 | $188 | $380 |
| Insertion of tube in right and left heart chambers and coronary artery for diagnosis with review by radiologist | 29 | $279 | $1,200 |
| Ultrasound of heart blood vessel or graft An ultrasound exam to evaluate blood flow in a heart blood vessel or graft, including a radiologist's review of the initial vessel. |
23 | $77 | $500 |
| Continuous ECG monitoring, up to 30 days Continuous heart rhythm monitoring for up to 30 days, including professional review and reporting of the results. |
21 | $22 | $75 |
| 30-day continuous ECG with patient-triggered event transmission and review This procedure involves continuous electrocardiogram monitoring for up to 30 days, including the transmission of patient-triggered events. A healthcare professional reviews the data and provides a report. |
21 | $804 | $1,500 |
| Wearable defibrillator system evaluation Assessment of a wearable cardioverter defibrillator to ensure proper function and fit. |
20 | $47 | $200 |
| Stent placement and plaque removal in one vessel A procedure to clear plaque and blood clots from a single blood vessel, followed by the insertion of a stent and/or balloon dilation to keep the vessel open. |
18 | $525 | $1,800 |
| Intravascular ultrasound of heart vessel, initial An ultrasound procedure used to evaluate a blood vessel within the heart during a diagnostic or treatment procedure. |
17 | $59 | $310 |
| Ultrasound of leg arteries or grafts An imaging test that uses sound waves to create pictures of the blood vessels in the legs or any surgical grafts present. |
16 | $200 | $350 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
14 | $134 | $280 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
6.2% high complexity
10.8% medium
83.0% routine
Industry Payment Transparency
Open Payments through 2024 ↗$64,143
Total received (2018-2024)
Avg $9,163/year across 7 years
Top 13% in CA for interventional cardiology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
51
Companies
1,038
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$40,681 (63.4%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$23,462 (36.6%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$6,634
2023
$6,926
2022
$6,575
2021
$9,249
2020
$5,301
2019
$11,497
2018
$17,961
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
AstraZeneca Pharmaceuticals LP
$2,089
Philips North America LLC
$1,061
CVRx, Inc.
$985
ABIOMED
$450
Boston Scientific Corporation
$246
Abbott Laboratories
$202
PFIZER INC.
$186
Novartis Pharmaceuticals Corporation
$182
Merck Sharp & Dohme LLC
$180
E.R. Squibb & Sons, L.L.C.
$153
Medtronic, Inc.
$126
Kiniksa Pharmaceuticals International, plc
$126
Novo Nordisk Inc
$121
ShockWave Medical, Inc
$114
Amgen Inc.
$88
Lexicon Pharmaceuticals, Inc.
$59
Alnylam Pharmaceuticals Inc.
$40
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$37
Janssen Pharmaceuticals, Inc
$37
ASAHI INTECC USA, INC.
$35
Edwards Lifesciences Corporation
$29
SCPHARMACEUTICALS INC.
$26
Boehringer Ingelheim Pharmaceuticals, Inc.
$22
iRhythm Technologies, Inc.
$21
Actelion Pharmaceuticals US, Inc.
$18
Top 3 companies account for 62.3% of 2024 payments
All-time payments by company (2018-2024) ›
AstraZeneca Pharmaceuticals LP
$18,712
Amgen Inc.
$13,960
Novartis Pharmaceuticals Corporation
$11,197
ABIOMED
$3,390
Acist Medical Systems, Inc.
$1,627
Janssen Pharmaceuticals, Inc
$1,305
Abbott Laboratories
$1,147
Philips North America LLC
$1,061
CVRx, Inc.
$1,036
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$1,009
Amarin Pharma Inc.
$878
E.R. Squibb & Sons, L.L.C.
$841
Actelion Pharmaceuticals US, Inc.
$716
Cardiovascular Systems Inc.
$605
PFIZER INC.
$598
SANOFI-AVENTIS U.S. LLC
$538
Boston Scientific Corporation
$457
Boehringer Ingelheim Pharmaceuticals, Inc.
$415
CARDIVA MEDICAL, INC.
$376
Medtronic, Inc.
$364
Gilead Sciences, Inc.
$361
Merck Sharp & Dohme LLC
$340
Allergan Inc.
$305
Esperion Therapeutics, Inc.
$299
ShockWave Medical, Inc
$260
Medtronic Vascular, Inc.
$221
Edwards Lifesciences Corporation
$215
Regeneron Healthcare Solutions, Inc.
$169
Impulse Dynamics (USA) Inc.
$166
Chiesi USA, Inc.
$165
Novo Nordisk Inc
$164
Kiniksa Pharmaceuticals, Ltd.
$150
Merck Sharp & Dohme Corporation
$137
Kiniksa Pharmaceuticals International, plc
$126
Baxter Healthcare
$105
Philips Electronics North America Corporation
$99
Alnylam Pharmaceuticals Inc.
$95
Kowa Pharmaceuticals America, Inc.
$65
Otsuka America Pharmaceutical, Inc.
$65
Lexicon Pharmaceuticals, Inc.
$59
iRhythm Technologies, Inc.
$53
ARBOR PHARMACEUTICALS, INC.
$47
Bayer HealthCare Pharmaceuticals Inc.
$39
Bardy Diagnostics, Inc.
$37
ASAHI INTECC USA, INC.
$35
Relypsa, Inc.
$34
SCPHARMACEUTICALS INC.
$26
BIOTRONIK INC.
$23
AngioDynamics, Inc.
$20
Avinger Inc.
$18
HeartFlow, Inc.
$16
Top 3 companies account for 68.4% of all-time payments
Associated products mentioned in payments ›
(5044) MCOT · (6342) Intrasight Integ · (6571) Eagle Eye · (BQ9) Coronary IVUS · 3F · AMPLATZER AMULET · ANDEXXA · AVEIR · Adempas · Arcalyst · BRILINTA · BYDUREON · BYSTOLIC · BYVALSON · Barostim Neo System · CAMZYOS · CARDIVA VASCADE MVP VVCS 6-12F · CHANTIX · COREVALVE EVOLUT R · COROFLOW · Carnation Ambulatory Monitor · Circulatory Support · Confirm Rx · CoreValve Evolut · Corlanor · Coronary Orbital Atherectomy System · Dragonfly OCT · ELIQUIS · ENTRESTO · Edarbi · Edwards SAPIEN 3 Transcatheter Heart Valve · Edwards SAPIEN 3 Ultra Transcatheter Heart Valve · FARXIGA · FFRct · FUROSCIX · HD-IVUS · Hillrom - Cardiac Ambulatory Monitor · Hillrom - Carnation Ambulatory Monitor · Impella · JARDIANCE · KENGREAL · LEQVIO · LINZESS · LifeVest · Livalo · MERLIN@HOME · MULTAQ · Micra · Mitra Clip system · MitraClip System · NEXLETOL · NEXLIZET · ONPATTRO · OPSUMIT · OPSUMIT MACITENTAN · OPTIMIZER · Ozempic · PANTHERIS · PERIPHERAL VASCULAR · PRADAXA · PRALUENT · PRALUENT ALIROCUMAB INJECTION · Perclose ProGlide suture mediated closure system · Peripheral Orbital Atherectomy System · Repatha · Reveal LINQ · Reveal XT · Rybelsus · SAMSCA · SAPIEN 3 Ultra RESILIA · SHOCKWAVE IVL SYSTEM WITH THE SHOCKWAVE C2 CORONARY IVL CATHETER · Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter · UPTRAVI · VERQUVO · VYNDAQEL · Vascepa · Veltassa · WAINUA · WATCHMAN · WATCHMAN Access System · WATCHMAN FLX · Wegovy · XARELTO · ZIO XT Patch
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
The majority of payments (63%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in interventional cardiology and does not inherently indicate bias, but patients may wish to be aware.
Geographic Context
Interventional cardiologists within 10 mi
9
Per 100K population
1.1
County median income
$107,327
Nearest hospital
ST JOHNS REGIONAL MEDICAL CENTER
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Rothschild is a clinical cardiology specialist, with above-average Medicare volume (top 8% in CA), with speaking/promotional industry engagement in the top 13% of CA peers, with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Rothschild experienced with chronic care management, additional 20 min/month?
Based on Medicare claims data, Dr. Rothschild performed 1,365 chronic care management, additional 20 min/month services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Rothschild receive payments from pharmaceutical companies?
Yes. Dr. Rothschild received a total of $64,143 from 51 companies across 1,038 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Rothschild's costs compare to other interventional cardiologists in Oxnard?
Dr. Rothschild's average Medicare payment per service is $95. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Rothschild) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Interventional Cardiologists in Oxnard
Browse interventional cardiologists in Oxnard ranked by procedure volume and transparency data.
Highest volume
Top Interventional Cardiologists in CA
Interventional cardiologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Interventional Cardiologists in CA
Which CA interventional cardiologists receive the most from drug and device companies.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
By company
Amgen Inc. Payments to Doctors
See all physicians who received payments from Amgen Inc.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology